EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

COMPARATIVE STUDY ON THE EFFICACY OF SAFUF-I BARAS AND NARROW BAND ULTRA-VIOLET B PHOTOTHERAPY IN BARA? (VITILIGO)- STUDY PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL

Dr. Meenu Doni* and Prof. Mohd. Aleemuddin Quamri

ABSTRACT

Background and objectives: Baraṣ (Vitiligo) is an autoimmune skin disorder that is characterized by patches of skin that lose pigments because of dysfunctional pigment-producing melanocytes being attacked by immune cells. Its exact etiopathogenesis is unknown. We here present the protocol of an interventional clinical phase II study to test the hypothesis, that Safūf-i Baraṣ alone and in combination with NB-UVB phototherapy may be effective among the cases of Non-Segmental Vitiligo. Methods: It is a Randomized Open-labelled Triple Arm Comparative Clinical Trial.150 patients with clinically diagnosed non-segmental vitiligo will be randomized to Group A (n=50), Group B (n=50) and Group C (n=50). In group A Safūf-i Baraṣ will be given Orally in the form of Zulāl and sediment is applied on selected lesions followed by exposure to sunlight daily for 20 minutes, for 60 days. In Group B only NB-UVB Phototherapy will be given on alternate days locally on the selected lesion for 60 days and in Group C Safūf-i Baraṣ will be given Orally in the form of Zulāl daily and NB-UVB Phototherapy will be given on alternate days for 60 days. The primary endpoint is the reduction in Vitiligo Extent Tensity Index (VETI) and Vitiligo Area Scoring Index (VASI) score. Secondary endpoints include changes in photographic lesions (re-pigmentation) and Improvements in the Dermatological Life Quality Index (DLQI).

Keywords: Baras, Saf?f-i Bara?, NB-UVB phototherapy, Non-segmental vitiligo, VASI,VETI,DLQI.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2025 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MARCH ISSUE PUBLISHED

    MARCH 2025 issue has been successfully launched on MARCH 2025.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here